JP MORGAN 2015: Roche in dealmaking mode post-Foundation deal
This article was originally published in Clinica
Executive Summary
Roche’s recent investment in molecular diagnostics player Foundation Medicine could be just the start for the Swiss firm. It told Clinica’s sister publication Scrip during the 33rd Annual JP Morgan Healthcare Conference in San Francisco that it is actively looking to do more deals.